家蚕抗菌肽-死亡素杂合肽基因在大肠杆菌中的克隆与表达

近年来的研究发现,抗菌蛋白在生物体非专一性防御系统有着重要的作用,已有数十种具有抗菌活性的多肽被分离,这些多肽可大致分为3类,即含分子内二硫桥的抗菌肽;具有双亲a-螺旋结构的抗菌肽;以及富含某种氨基酸残基的抗菌肽[1],一般来说,这些抗菌肽具有分子量小,稳定性好,无细胞毒性,抗菌谱广等特点.多种抗菌肽的一级结构和二级结构已经确定[2],但作用机理仍不明了.一般认为可能存在两种作用模式,即1)通过肽-脂膜相关作用杀菌;2)通过受体介导的识别过程起作用[1].     

蛙皮素-蜂毒素杂合肽基因在大肠杆菌中的克隆与诱导表达

抗菌肽 (Ａｎｔｉｂａｃｔｅｒｉａｌｐｅｐｔｉｄｅｓ)原指昆虫体内经诱导产生的一类分子量在 4ｋＤ左右 ,具有抗菌活性的碱性多肽物质[2 ] 。这类抗菌剂最初是从昆虫、哺乳动物、两栖动物等的防御系统中分离得到的。抗菌肽对革兰氏阳性及阴性细菌、病毒、原虫和发生病变的真核细胞等有杀伤作用 ,具有很强的广谱抑菌作用 ,但对正常哺乳动物细胞无杀伤作用[3 ] 。蛙皮素还具有抗肿瘤活性而没有溶血活性[4 ] ,虽然蜂毒素具有溶血活性 ,但其溶血功能区位于Ｃ端的亲水区域[5] ,两者的极性区域正好相反。据研究表明抗菌肽都会形成两亲螺旋结构的…     

蜘蛛抗菌肽研究进展

蜘蛛活性多肽研究主要集中于蜘蛛毒液中作用于离子通道的神经毒素多肽。但近年来,一些蜘蛛抗菌肽不断被分离纯化,其结构和抗菌活性也被广泛深入研究,这将成为蜘蛛活性多肽研究领域的一个新热点。在蜘蛛毒液和血液中,存在不同种类的抗菌肽,其多肽长度、结构、抗菌作用各不相同。而且,有些抗菌肽甚至具有抗肿瘤作用。概述了蜘蛛抗菌肽在结构和功能方面的研究进展。     

含有Fxa切割位点的抗菌肽X在大肠杆菌中的融合表达

抗菌肽是昆虫体液免疫的重要成分[1,2 ] ,它们的分子量较小 ,具有抗菌、抗病毒和杀伤某些肿瘤细胞的功能 ,而不破坏人体正常细胞。基于它的这种选择性效应和分子小、无抗原性的特点 ,可望成为新一代的抗菌、抗肿瘤药物。然而 ,天然抗菌肽来源十分困难 ,不能满足研究和临床应用的需要 ,通过基因工程技术生产抗菌肽已成为人们普遍关注的焦点。抗菌肽ＣＭＩＶ是从家蚕蛹中分离并测定了其一级结构的新型抗菌肽 ,它由 35个氨基酸组成 ,不含甲硫氨酸 ,Ｃ 末端为酰胺[3 ] 。抗菌肽Ｘ是中国家蚕抗菌肽ＣＭＩＶ的变体 ,其一级结构与天然的抗菌肽ＣＭ…     

抗菌肽CMIV末端结构对其活性的影响

抗菌肽作为一种新型多肽药物越来越受到人们的重视.但是到目前为止对于抗菌肽的作用机理仍然不太明确.将抗菌肽CMIV基因及其变体基因X克隆入GST融合表达系统.分别用不同的切割试剂切割后得到N-端具有多余氨基酸的抗菌肽CMIV以及C-端未酰胺化的抗菌肽CMIV,这些多肽均丧失了抗菌活性,而N-端无多余氨基酸,以及C-端加进1个天冬酰胺的多肽具有抗菌活性.实验结果提示:抗菌肽原有的末端结构对其生物活性至关重要.     

抗菌肽结构与功能关系及分子改造研究进展

抗菌肽是生物体产生的一种具有抗菌活性的多肽小分子,具有广谱、特异性的抗菌、抗病毒、抗肿瘤等作用。研究表明抗菌肽的正电荷含量、疏水性和肽链结构对抗菌肽的活性至关重要的。围绕以上三个方面对抗菌肽进行分子设计和改造,以期更加有效地提高抗菌肽的抗菌活性,获得到更加高效、低毒的抗菌肽产品。该文主要通过抗菌肽结构与功能的关系,介绍抗菌肽分子设计的研究进展。     

中国林蛙和中华蟾蜍皮肤抗菌肽的分离纯化及其抗菌活性

分别以中国林蛙长白山亚种Rana chensinensis changbaishansis和中华蟾蜍Bufo gargarizans的鲜皮为原料,通过酸化乙醇法提取抗菌肽粗提液,再经葡聚糖凝胶层析进一步分离纯化获得抗菌肽纯品,采用滤纸片法进行抑菌活性研究.结果 表明,经Sephadex G-50和Sephadex G-100分离纯化后获得3种多肽,中国林蛙与中华蟾蜍皮肤中的活性多肽对革兰氏阴性和革兰氏阳性细菌都具有一定的抗菌作用,其中多肽Ⅲ具有最佳的抑菌效果.抗菌肽相对含量比较的结果表明,蟾蜍皮肤中抗菌活性肽的含量较高,是理想的抗菌肽提出和纯化的源材料.     

沼水蛙抗菌肽brevinin-2GHa1分离纯化及结构分析

目前,已自青蛙皮肤分泌物中分离获得多种具有较强抗菌活性的多肽．本文利用电刺激法自沼水蛙背腺和耳后腺获得其皮肤分泌物,利用凝胶过滤色谱(Sephadex G-50)和反相高效液相色谱 (reverse-phase high performance liquid chromatography, RP-HPLC)分离纯化,获得一种新型抗菌肽,命名为brevinin- 2GHa1. 抑菌实验显示,该抗菌肽对革兰氏阳性菌和革兰氏阴性菌均有抑制作用,对大肠杆菌、金黄色葡萄球菌、枯草芽孢杆菌和沙门氏菌的最小抑制浓度分别为： 7.8、3.9、2.0 μg/mL和250.0 μg/mL. 该抗菌肽在水中为无规卷曲结构,在浓度为10 mmol/L SDS水溶液和不同浓度三氟乙醇水溶液中则呈α-螺旋结构,该抗菌肽结构的研究对阐明其抑菌机制具有重要作用.     

天然抗菌肽的研究进展及应用前景

天然抗菌肽是生物体内经诱导产生的一种具有抗菌活性的小分子多肽,来源广泛。目前已从多种物种中分离纯化出千余种抗菌肽,其分子量大约在3～6kD之间,由20～60个氨基酸残基组成。天然抗菌肽具有多种生物活性,如抗细菌、抗真菌、抗病毒和抗癌细胞等作用。综述了天然抗菌肽的分类、生物活性及其作用机理和应用前景。     

抗菌肽Cecropin及其在转基因植物抗菌中的应用

Cecropin抗菌肽,又名天蚕素,是一类具有抗菌能力的小分子多肽,热稳定性好,抗菌谱广,在各个应用领域已经得到广泛的研究。本文就Cecropin抗菌肽结构与功能的关系、作用机制和其在转基因植物抗菌领域中的应用进行综述,转基因植物表达Cecropin抗菌肽具有应用优势和实用价值,Cecropin抗菌肽分子结构与作用机制探索的深入能进一步促进转基因植物抗菌研究的发展。     

Covalent structure of collagen: amino acid sequence of three cyanogen bromide-derived peptides from human alpha 1(V) collagen chain

Type V collagen was prepared from human amnionic/chorionic membranes and separated into alpha 1(V) and alpha 2(V) polypeptide chains. The alpha 1(V) chain was digested with cyanogen bromide and nine peptides were obtained and purified. Three of the peptides, alpha 1(V)CB1, CB4, and CB7 having molecular weights of 5000, 8000, and 6000, respectively, were further analyzed by amino acid sequence analysis and thermolytic or tryptic digestions. CB1 contained 54 amino acids and identification of its complete sequence was aided by thermolysin digestion and isolation of two peptides, Th1 and Th2. CB4 contained 81 amino acids and sequence analysis of intact CB4 and five tryptic peptides provided us with its complete amino acid sequence. The peptide CB7 contained 67 amino acids and was cleaved into four tryptic peptides that were used for complete sequence analysis. The above results represent the first available covalent structure information on the alpha 1(V) collagen chain. These data enabled us to establish the location of these peptides within the helical structure of other collagen chains. CB4 was homologous to residues 66-145 in the collagen chain while CB1 represented residues 146-200 and CB7 was homologous with residues 201-269. This alignment was facilitated by identification of a helical collagen crossing site consisting of Hyl-Gly-His-Arg located at positions 87-90 in all collagen chains of this size thus far identified. Seventy-one percent homology (excluding Gly residues) was found between amino acids in this region of the alpha 1(XI) and of alpha 1(V) collagen chains while only 21 and 19% identity was calculated for the same region of alpha 2(V) and alpha 1(I) collagen chains, respectively.     

Primary structure of human alpha 2-macroglobulin. I. Isolation of the 26 CNBr fragments, amino acid sequence of 13 small CNBr fragments, amino acid sequence of methionine-containing peptides, and alignment of all CNBr fragments

The isolation of the 26 CNBr fragments from the identical Mr = 180,000 subunits of human alpha 2-macroglobulin is described. The fragments have been purified by combinations of gel chromatography, ion-exchange chromatography, high voltage paper electrophoresis, paper chromatography, and high performance liquid chromatography. The complete amino acid sequences of 13 small CNBr fragments have been determined. These fragments include CB1 (residues 1-9), CB3 (residues 79-98), CB4 (residues 99-128), CB9 (residues 442-477), CB10 (residues 478-497), CB13 (residues 644-650), CB14 (residues 651-665), CB15 (residues 666-674), CB16 (residues 675-690), CB19 (residues 937-945), CB20 (residues 946-954), CB24 (residues 1356-1362), and CB25 (residues 1363-1375). The fragments determined account for 200 of the 1451 residues of the subunits of alpha 2-macroglobulin. Most likely, Cys-6 of CB9 is bound to the corresponding residue in CB9 from another subunit, thus forming an interchain disulfide bridge in alpha 2-macroglobulin. Cys-1 of CB15 is bound to Cys-35 of CB12. CB15 contains a pair of Gln residues that can react covalently with amines in a factor XIIIa-catalyzed process (Gln-5 and Gln-6). CB16 contains the primary cleavage sites for proteinases in the bait region of alpha 2-macroglobulin (-Arg7-Val-Gly-Phe-Tyr-Glu-). CB20 contains the residues which in native alpha 2-macroglobulin presumably form an internal reactive beta-cysteinyl-gamma-glutamyl thiol ester (Cys-4 and Glx-7). Partial NH2- and COOH-terminal sequence data are given for the 13 large CNBr fragments. Complete or partial sequence determination of 19 methionine-containing peptides or variants thereof allow the alignment of all the CNBr fragments.     

Structural analysis of multiple bovine P-450(11 beta) genes and their promoter activities

A bovine genomic library was constructed using a cosmid vector, pHC79, and bovine DNA partially digested by EcoRI. Bovine P-450(11 beta) cDNA, pcP-450(11 beta)-2 [Morohashi et al. (1987) J. Biochem. 102,559-568], was used as a probe for screening the genomic library. Ten clones carrying P-450(11 beta) genomic DNA were isolated from 8 x 10(4) colonies and classified into five groups (CB11 beta-1, CB11 beta-3, CB11 beta-7, CB11 beta-20, and CB11 beta-21) according to differences in the restriction endonuclease sites. Nucleotide sequences of amino acid coding regions of the five clones were determined by the dideoxy sequencing method using synthetic nucleotides corresponding to various parts of the cDNA as primers. The nucleotide sequences revealed that three clones, CB11 beta-1, CB11 beta-3, and CB11 beta-21, were pseudogenes. Amino acid sequences coded by the other two clones, CB11 beta-7 and CB11 beta-20, were identical with that coded by a previously described cDNA, pcP-450(11 beta)-3 [Kirita et al. (1988) J. Biochem. 104, 683-686]. The promoter regions of the five clones were introduced in front of chloramphenicol acetyltransferase (CAT) gene of pSV00CAT and used to examine P-450(11 beta) gene regulation in cultured cells. The five recombinant plasmids showed cAMP-responsive CAT activities in Y-1 cells, a cell strain derived from adrenal tumor. The induction rates of the recombinant plasmids carrying the promoters of normal genes, CB11 beta-7 and -20, were larger than those of pseudogenes, CB11 beta-1, -3, and -21. CAT activities expressed by the promoter regions of the normal genes in the presence or absence of cAMP in Y-1 cells were almost equal to that by the promoter region of human P-450(SCC) gene. Though the promoter of the P-450(SCC) gene also showed cAMP-responsive CAT activity in I-10 cells, a cell strain derived from Leyding cell tumor, P-450(11 beta) gene promoter did not express the activity in I-10 cells.     

Primary structure of tyrosinase from Neurospora crassa. I. Purification and amino acid sequence of the cyanogen bromide fragments

Cyanogen bromide (CB) cleavage of Neurospora tyrosinase resulted in four major fragments, CB1 (222 residues), CB2 (82 residues), CB3 (68 residues), and CB4 (35 residues), and one minor overlap peptide CB2-4 (117 residues) due to incomplete cleavage of a methionylthreonyl bond. The sum of the amino acid residues of the four major fragments matches the total number of amino acid residues of the native protein. The amino acid sequences of the cyanogen bromide fragments CB2, CB3, and CB4 were determined by a combination of automated and manual sequence analysis on peptides derived by chemical and enzymatic cleavage of the intact and the maleylated derivatives. The peptides were the products of cleavage by mild acid hydrolysis, trypsin, pepsin, chymotrypsin, thermolysin, and Staphylococcus aureus protease V8. The cyanogen bromide fragment CB1 was found to contain two unusual amino acids whose chemical structure will be presented in the following paper.     

Analysis of wild-type and mutant p21WAF-1 gene activities.

The p21WAF-1 gene is positively regulated by the wild-type p53 protein. p21WAF-1 has been shown to interact with several cyclin-dependent kinase complexes and block the activity of G1 cyclin-dependent kinases (cdks). Mutational analysis with the p21WAF-1 gene localized a site, at amino acid residues 21 and 24 in the amino terminus of the protein, for p21WAF-1 binding to cyclins D and E. This region of the protein is conserved (residues 21 to 26) in other p21WAF-1 family members, p27kip-1 and p57kip-2. The same p21WAF-121,24 mutant also fails to bind to cyclin D1-cdk 4 or cyclin E-cdk 2 complexes in vitro, suggesting that amino acid residues 21 and 24 are important for p21WAF-1-cdk-cyclin trimeric complex interactions. The p21WAF-1 wild-type protein will suppress tumor cell growth in culture while p21WAF-1 mutant proteins with defects in residues 21 and 24 fail to suppress tumor cell growth. The overexpression of cyclin D or E in these cells will partially overcome the growth suppression of wild-type p21WAF-1 protein in cells. These results provide evidence that p21WAF-1 acts through cyclin D1-cdk4 and cyclin E-cdk2 complexes in vivo to induce the growth suppression. The p21WAF-1 binding sites for cyclins (residues 21 to 26), cdk2 (residues 49 to 71), and proliferating-cell nuclear antigen (residues 124 to 164) have all been mapped to discrete sites on the protein.     

Purification of twelve cyanogen bromide fragments from bovine plasma fibronectin and the amino acid sequence of eight of them. Overlap evidence aligning two plasmic fragments, internal homology in gelatin-binding region and phosphorylation site near C terminus

Twelve cyanogen bromide fragments (CB1-12) from bovine plasma fibronectin have been isolated and eight of these completely sequenced. Altogether they account for 502 of the total expected 1880 residues in each of the two chains of fibronectin. Four of these fragments (CB1-4) constitute residues 1-289 in fibronectin with CB4 overlapping the N-terminal 29-kDa plasmic fragment to the second plasmic fragment, of 170-kDa in fibronectin. Fragments CB 5-9 are all contained within a 45-kDa gelatin-binding region, which is N-terminal in the 170-kDa fragment. The sequence of two of these five fragments in the 45-kDa fragment (CB7-8) contains two mutually homologous stretches with 57% sequence identity. Another two fragments (CB10-11) are derived from the heparin-binding region of the 170-kDa fragment. CB12 constitutes the C-terminal 13-residue stretch in fibronectin and contains a partly phosphorylated serine residue in the C-terminal sequence: -Arg-Glu-Asp-Ser(P)-Arg-Glu.     

Changing the antigen binding specificity by single point mutations of an anti-p24 (HIV-1) antibody

The murine mAb CB4-1 raised against p24 (HIV-1) recognizes a linear epitope of the HIV-1 capsid protein. Additionally, CB4-1 exhibits cross-reactive binding to epitope-homologous peptides and polyspecific reactions to epitope nonhomologous peptides. Crystal structures demonstrate that the epitope peptide (e-pep) and the nonhomologous peptides adopt different conformations within the binding region of CB4-1. Site-directed mutagenesis of the fragment variable (Fv) region was performed using a single-chain (sc)Fv construct of CB4-1 to analyze binding contributions of single amino acid side chains toward the e-pep and toward one epitope nonhomologous peptide. The mutations of Ab amino acid side chains, which are in direct contact with the Ag, show opposite influences on the binding of the two peptides. Whereas the affinity of the e-pep to the CB4-1 scFv mutant heavy chain variable region Tyr(32)Ala is decreased 250-fold, the binding of the nonhomologous peptide remains unchanged. In contrast, the mutation light chain variable region Phe(94)Ala reduces the affinity of the nonhomologous peptide 10-fold more than it does for the e-pep. Thus, substantial changes in the specificity can be observed by single amino acid exchanges. Further characterization of the scFv mutants by substitutional analysis of the peptides demonstrates that the effect of a mutation is not restricted to contact residues. This method also reveals an inverse compensatory amino acid exchange for the nonhomologous peptide which increases the affinity to the scFv mutant light chain variable region Phe(94)Ala up to the level of the e-pep affinity to the wild-type scFv.     

Chondrocyte hypertrophy can be induced by a cryptic sequence of type II collagen and is accompanied by the induction of MMP-13 and collagenase activity: implications for development and arthritis.

The objective of this study was to determine whether a peptide of type II collagen which can induce collagenase activity can also induce chondrocyte terminal differentiation (hypertrophy) in articulate cartilage. Full depth explants of normal adult bovine articular cartilage were cultured with or without a 24 mer synthetic peptide of type II collagen (residues 195-218) (CB12-II). Peptide CB12-II lacks any RGD sequence and is derived from the CB12 fragment of type II collagen. Type II collagen cleavage by collagenase was measured by ELISA in cartilage and medium. Real-time RT-PCR was used to analyze gene expression of the chondrocyte hypertrophy markers COL10A1 and MMP-13. Immunostaining for anti-Ki67, anti-PCNA, (proliferation markers), type X collagen, cleavage of type II collagen by collagenases (hypertrophy markers) and TUNEL staining (hypertrophy and apoptosis markers) were used to detect progressive maturational stages of chondrocyte hypertrophy. At high but naturally occurring concentrations (10 microM and up) the collagen peptide CB12-II induced an increase in the expression of MMP-13 (24 h) and cleavage of type II collagen by collagenase in the mid zone (day 4) and also in the superficial zone (day 6). Furthermore the peptide induced an increase in proliferation on day 1 in the mid and deep zones extending to the superficial zone by day 4. There was also upregulation of COL10A1 expression at day 4 and of type X staining in the mid zone extending to the superficial zone by day 6. Apoptotic cell death was increased by day 4 in the lower deep zone and also in the superficial zone at day 7. The increase in apoptosis in the deep zone was also seen in controls. Our results show that the induction of collagenase activity by a cryptic peptide sequence of type II collagen, is accompanied by chondrocyte hypertrophy and associated with cellular and matrix changes. This induction occurs in the mid and superficial zones of previously healthy articular cartilage. This response of the chondrocyte to a cryptic sequence of denatured type II collagen may play a role in naturally occurring hypertrophy in endochondral ossification and in the development of cartilage pathology in osteoarthritis.     

Nonenzymatic glycation of type I collagen. The effects of aging on preferential glycation sites.

The present study was designed to investigate the effects of aging on preferential sites of glucose adduct formation on type I collagen chains. Two CNBr peptides, one from each type of chain in the type I tropocollagen molecule, were investigated in detail: alpha 1(I)CB3 and alpha 2CB3-5. Together these peptides comprise approximately 25% of the total tropocollagen molecule. The CNBr peptides were purified from rat tail tendon, obtained from animals aged 6, 18, and 36 months, by ion exchange chromatography, gel filtration, and high-performance liquid chromatography (HPLC). Sugar adducts were radiolabeled by reduction with NaB3H4. Glycated tryptic peptides were prepared from tryptic digests of alpha 2CB3-5 and alpha 1(I)CB3 by boronate affinity chromatography and HPLC. Peptides were identified by sequencing and by compositional analysis. Preferential sites of glycation were observed in both CB3 and alpha 2CB3-5. Of the 5 lysine residues in CB3, Lys-434 was the favored glycation site. Of the 18 lysine residues and 1 hydroxylysine residue in alpha 2CB3-5, 3 residues (Lys-453, Lys-479, and Lys-924) contained more than 80% of the glucose adducts on the peptide. Preferential glycation sites were highly conserved with aging. In collagen that had been glycated in vitro, the relative distribution of glucose adducts in old animals differed from that of young animals. In vitro experiments suggest that primary structure is the major determinant of preferential glycation sites but that higher order structure may influence the relative distribution of glucose adducts among these preferred sites.     

Effect of chronic ethanol exposure and its withdrawal on the endocannabinoid system

The present study investigated the effect of ethanol (EtOH) exposure and its withdrawal on the central endocannabinoid system utilizing an EtOH vapor inhalation model, which is known to produce functional tolerance and dependence to EtOH. Swiss Webster mice (n=24) were exposed to EtOH vapors for 72h. Mice were sacrificed after 72h following EtOH exposure (n=12) and 24h after its withdrawal (n=12). Radioligand binding assays were performed to measure the density of CB(1) receptor and CB(1) receptor agonist-stimulated [(35)S]GTPgammaS binding in crude synaptic membranes isolated from the cortex, hippocampus, striatum and cerebellum. The density of CB(1) receptor was significantly decreased (31-39%) in all the brain regions when compared to the control group. The CB(1) receptor-stimulated G(i/o) protein activation was also found to be decreased (29-40%) in these brain regions of EtOH exposed mice. Recovery of the CB(1) receptor density, in addition to, the CB(1) receptor-mediated G-protein activation was observed after 24h withdrawal from EtOH. The levels of cortical anandamide, which was significantly increased (147%) by EtOH exposure, returned to basal levels after 24h of withdrawal from EtOH exposure. A significant reduction (21%) in the activity of fatty acid amide hydrolase was found in the cortex of EtOH administered mice. Taken together, the neuroadaptation in the EC system may have a potential role in development of tolerance and dependence to EtOH.